ArticleNanomedicine (London, England)2016

Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.

Ketan Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.